Guangzhou, China

Guangjin Pan

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Chinese Academy of Sciences. Active years: 2018.



 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Guangjin Pan

Introduction

Guangjin Pan is a notable inventor based in Guangzhou, China. He has made significant contributions to the field of stem cell research, particularly in the development of culture mediums for neural stem cells. His work has implications for regenerative medicine and cellular therapies.

Latest Patents

Guangjin Pan holds a patent titled "Culture medium for preparing neural stem cells and use thereof." This patent describes a culture medium that includes a basic culture medium suitable for the growth of stem cells, along with a cell signal pathway inhibitor selected from various inhibitors such as GSK inhibitor, MEK inhibitor, TGF-β inhibitor, ROCK inhibitor, and BMP inhibitor. He has 1 patent to his name.

Career Highlights

Throughout his career, Guangjin Pan has worked with prestigious institutions, including the Chinese Academy of Sciences and Hefei Stem Cell and Regenerative Medicine Co., Ltd. His research has focused on advancing the understanding and application of neural stem cells in medical science.

Collaborations

Guangjin Pan has collaborated with notable colleagues in his field, including Lihui Wang and Yanting Xue. Their combined efforts have contributed to the advancement of stem cell research and its applications.

Conclusion

Guangjin Pan's innovative work in the field of neural stem cells highlights his importance as an inventor in regenerative medicine. His contributions continue to influence the scientific community and pave the way for future advancements.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…